Timbercreek Stops Waiting: A $33 Million Vancouver Markdown and a Dividend on the Clock
Five quarters of "we're comfortable with the marks" ended with a $32 million quarterly loss, a payout ratio heading to 135%, and a land sale that management now says it cannot afford to wait out.
TF.TO · Earnings Call · 2026-11-12
The quarter where the waiting ended
Timbercreek Financial's third quarter was operationally fine and financially ugly. Net investment income was flat year-over-year at $25 million; distributable income held at $14 million, or $0.17 a share; advances of roughly $229 million helped push nine-month net new originations to $453 million against $258 million a year earlier, and the net mortgage book grew about 15% to $1.22 billion. Then the marks hit: $40 million of expected credit losses plus a $4.8 million fair-value loss, producing a reported net loss of $32.1 million, or $0.39 a share, against $0.10 of earnings before ECL.
Roughly $33 million of that ECL is one asset — the Vancouver retail/development assembly, now 71% of everything left in Stage 3 and the adjoining bucket. The Vancouver portfolio is no longer framed as a valuation question but as an execution question.
We're holding on to the asset and waiting for a better market is really no longer going to be measured in months. It could be years. The project does not generate meaningful cash flow... We would just be running to stand still at best.
That is the pivot. For a lender whose entire model is collecting spread on income-producing commercial mortgages, admitting that a non-earning asset has an opportunity cost rather than just a carrying cost is a different kind of confession, and it is the reason this quarter matters. Scott Rowland put the magnitude plainly: Vancouver multifamily land values have fallen “from peak values of $300 to $400 a foot to lows of $100 to $150 a foot today.” — Scott Rowland, Chief Investment Officer · 2026-11-12
Five quarters of "we're comfortable"
What makes the write-down a story rather than an accident is the paper trail behind it. In February 2026, management described the largest Vancouver component as coming to market that quarter: “That asset is actually going to go up for sale in Q1 this year... we would expect and are very hopeful for resolution of that in later Q2, Q3.” — Scott Rowland, Chief Executive Officer · 2026-02-26 On the same call, asked whether a bid below carrying value would be acceptable, the answer leaned on the mark: “we feel pretty good about where we think market pricing is going to be.” — Scott Rowland, Chief Executive Officer · 2026-02-26 By July 2026, when an analyst pressed on whether current valuations were believed, the response was an unhedged “Absolutely. Today.” — Robert Tamblyn, President and CEO · 2026-07-30 That same call guided that the remaining stage loans would have "much better visibility to resolution by the end of the year or be resolved."
Two quarters later, $33 million of Vancouver value evaporated and the timeline moved again — letters of intent hoped for before year-end, closing targeted for the end of Q1 2027. This is the third schedule for the same file. The point is not that management was dishonest; land markets in Vancouver and Toronto genuinely deteriorated through policy, development levies and immigration-driven demand shifts. The point is that the company's own disclosure rhythm has been mark, then discover, and investors should price the next mark accordingly — even as Blair Tamblyn insists book value “is not going to end up is something that starts with a 4 or 5.” — Robert Tamblyn, President & CEO · 2026-11-12
What management started saying — and stopped saying
The linguistic shift in this transcript is unusually clean. A new phrase, focused review, describes a board-level exercise completed with management to accelerate resolutions rather than wait out the cycle. A second, earning capacity, is the mechanism: active management converts a non-earning Stage 3 asset into recovered capital that can be re-lent at current market yields.
“We are clearly not satisfied with where our share price is today. We recognize shareholders' concerns around the level of staged loans, the pace of the resolution and the impact these positions are having on the earnings capacity of the portfolio.” — Robert Tamblyn, President & CEO · 2026-11-12
And the word that has quietly left the vocabulary is patience. In prior calls the stage loans were a list of workstreams with a roughly stable 6%-8% steady-state share of the book. Now they are the binding constraint on the dividend.
“We currently expect the payout ratio to increase temporarily to approximately 135% in Q4 and remain elevated through the Vancouver sale process, which is currently expected to be completed by the end of Q1 2027.” — Tracy Johnston, Chief Financial Officer · 2026-11-12
The 101.9% third-quarter payout ratio and 99.3% nine-month figure were already thin; 135% is a distribution being funded out of a reserve of credibility. Asked what would trigger a cut, Tamblyn gave the most honest line on the call: “we're not going to pay out more than we're earning for very long.” — Robert Tamblyn, President & CEO · 2026-11-12 Read that as a soft pre-announcement, not a reassurance. Dividend coverage is now the whole thesis.
The quiet detail: covenant headroom
Buried in the Q&A is a fact that deserves more attention than it got. The company negotiated forward-looking relief on its credit facility while ~$513 million was drawn — roughly 98% utilization — with the portfolio unable to grow into its line until Vancouver clears.
“There were no waivers for this quarter. I'll be clear. There were no covenant breaches. It was done on a forward-looking basis as we continue to work through this Vancouver portfolio. So just negotiated enough headroom for us to get through this on an interim basis.” — Tracy Johnston, Chief Financial Officer · 2026-11-12
No breach, but a lender and borrower agreeing in advance that the existing covenant package might not hold through the workout. That is a lender's opinion about the collateral, and it complements the ECL. It also explains why the sale process on the Granville block has to conclude — the balance sheet is fully drawn and syndication, which ran to $885 million in the first nine months versus $628 million a year ago, is doing the heavy lifting on capacity.
The redeployment bet
The bull case is straightforward and, to be fair, supported by real numbers. Since the start of 2023 the company has resolved more than $212 million of Stage 2 and Stage 3 exposure. Two GTA positions with roughly $44 million of combined net carrying value have letters of intent. The core book — 94.8% first mortgages, 69.8% weighted average LTV, 63% multi-residential, 82.6% cash flowing — is untouched by the problem. Manageable resets mean new loans are underwritten at lower basis, and the weighted average interest rate of 7.6% may actually drift up to the high 7s by 2027 as non-earning loans are replaced and prime adds another quarter point.
Strip out the Granville block and stage loans are already back to roughly 6%-8% of the portfolio — the historical norm. That is the punchline management wants: the problem is one asset, it is in the market, and once it clears, earning capacity returns immediately.
The risk is timing and price. Every extra quarter at a 135% payout draws down the cushion, and the recovery value is set by a bid deadline the company does not control. For a roughly $246 million market cap lender carrying a $1.22 billion book, a small-cap with binary-ish execution risk, the honest framing is this: the write-down was the price of ending the wait, and the dividend is now collateral for finishing the job quickly.